Neuralink Receives FDA’s Clinical Study Approval

by Bill Parson | May 26, 2023 | General News

Alon Musk’s machine-to-human interface company, Neuralink announced via Twitter they received the FDA’s approval to begin first-in-human clinical trials. For those of you brave enough who wish to participate in the future trial, you can register on Neuralink’s Patient Register.

We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!

This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…
— Neuralink (@neuralink) May 25, 2023

Neuralink’s Twitter Announcement

by: Bill Parson

Bill is an accomplished editor with a passion for robotics and emerging technologies. With a keen eye for detail and a knack for concise communication, he plays a pivotal role in developing and publishing content for SimplyBots. His deep interest in the field of robotics stems from his fascination with the potential of intelligent machines to transform various aspects of our lives.